Conduit Pharmaceuticals- Warrants (22/09/2028) (CDTTW) has a profit margin of 12.85%, below the sector sector average of 21.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), CDTTW shows a profit margin of 12.85%. That compares with 6.29% in the prior-year period — up 104.5% year over year. That is below the sector sector average of 21.34%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CDTTW's profit margin is now 12.85% (was 6.29%) — a 104.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Conduit Pharmaceuticals- Warrants (22/09/2028) is outperforming or lagging.
The its sector sector average profit margin is about 21.34%. Conduit Pharmaceuticals- Warrants (22/09/2028) is at 12.85%, which is lower that average. That is roughly 39.8% below the sector mean. Use the comparison chart on this page to see how CDTTW stacks up against individual peers as well.
That compares with 6.29% in the prior-year period — up 104.5% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Conduit Pharmaceuticals- Warrants (22/09/2028) with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Conduit Pharmaceuticals- Warrants (22/09/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 12.85%) with ownership activity and broader fundamentals.